- MY ACCOUNT
Title: What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis
Title: Symptom/rhythm correlation with patient owned device: Insights into practice and challenges
Title: Determining esophageal anatomy with a new electroanatomical mapping system
Title: The Autonomic Nervous System and Atrial Fibrillation: The Roles of Pulmonary Vein Isolation and Ganglionated Plexi Ablation
Title: Trigger Versus Substrate Ablation for Atrial Fibrillation.
Credits: Atul Verma, MD, FRCPC
Affiliation: Associate Professor of Medicine Director, EP Training Program Queen?s University, Kingston, Ontario, Canada, Board of trustees ISHNE, Council Member International Society of Electrocardiography (ISE), His area of interest is the link between AFib and Sleep Apnea
Affiliation: Dr. Girish Nair graduated from the Jawaharlal Nehru Institute of Post Graduate Medical Education and Research (JIPMER- a deemed University), Pondicherry, India. He completed his residency in Internal Medicine and Cardiology from the University of Delhi, India. He moved to Canada in 2002 and completed a clinical/research fellowship in Interventional Cardiac Electrophysiology from the University of Toronto and associated Toronto General Hospital. Dr. Nair has also completed his MSc. in Health Research Methodology form McMaster University. He served as a faculty in the Division of Cardiology at McMaster University from 2004 to 2012. Dr. Nair joined the Division of Cardiology at the University of Ottawa Heart Institute at the rank of Associate Professor on the 1st of October 2012. Dr. Nair’s current research interests lie in the fields of Atrial Fibrillation, Sudden Cardiac Death and Ventricular tachycardia with a specific focus on evaluating treatment strategies and knowledge transfer. His clinical focus is on complex ablations including Atrial Fibrillation, Ventricular Tachycardia and arrhythmias in the grown up congenital heart disease population.
Affiliation: Professor of Neurology and Clinical Pharmacology, and Director of the Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, Canada. Professor Spence has devoted his entire career to stroke prevention. His interests include individualized therapy for resistant hypertension and nutrition in stroke prevention (including vitamin therapy to lower homocysteine). He was a co-discoverer of the effect of grapefruit on drug metabolism, and pioneered the measurement of carotid plaque burden by ultrasound for patient management, genetic research and evaluation of new therapies.
Affiliation: Cardiologist Electrophysiologist at the Montreal Heart Institute and Clinical Assistant Professor at the University of Montreal, Montreal, Quebec, Canada.
Affiliation: Marie-France Beauchesne is pharmacist at the CIUSSS de l’Estrie – CHUS, and professor of clinical pharmacy at the Faculté de pharmacie, Université de Montréal. Her research interests include optimal medication prescribing and management
Affiliation: Dr. Sameer Bansilal is a clinician and investigator with a broad range of expertise in cardiovascular medicine and outcomes research on a global scale. Dr. Bansilal is currently an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai and an Attending Physician in the Mount Sinai Cardiovascular Institute. Prior to this he was investigator at the TIMI Study Group at Brigham and Women’s Hospital, Boston, MA, founded by Eugene Braunwald, MD. Dr. Bansilal earned his medical degree from University of Mumbai, India and completed his residency training in Internal Medicine at New York Methodist Hospital, New York. He went on to complete a research fellowship followed by a clinical cardiology fellowship at Mount Sinai, New York under the tutelage of Valentin Fuster, M.D, Ph.D. During this time, Dr. Bansilal obtained a Masters in Clinical Research from the Mount Sinai-NYU Program and additional training at the Harvard School of Public health through the program in clinical effectiveness. Dr. Bansilal has experience with federally funded trials (FREEDOM) and multiple pharmaceutical sponsored trials (PEGASUS TIMI-54, DECLARE TIMI-58) through his work in New York and Boston. Dr. Bansilal’s research interests include evaluation of therapies for coronary disease, diabetes, atrial fibrillation and valvular heart disease in global populations. His special interests include advanced trial design and trial methodology. His clinical interests center on patients with diabetes, coronary disease, atrial fibrillation, valvular disease and asymptomatic patients with various heart disorders.
Affiliation: Zardasht Oqab is a second year Adult Cardiology fellow at the University of Calgary and Libin Cardiovascular Institute of Alberta in Canada. He completed his internal medicine training at Queen’s University in Kingston, Ontario, Canada. Dr. Oqab was the recipient of the 2016 Junior Investigator Award from the Canadian Stroke Prevention Intervention Network for his work in atrial fibrillation and frailty. His ongoing research interests are atrial fibrillation, frailty and syncope.
Affiliation: EP followship from University of Ottawa heart Institute. Working at present at the Royal Hospital (from 2007), Sultanate of Oman, In charge of Arrhythmia service, Department of Cardiology. Working as a senior consultant and heading one of the cardiology units with special focus on arrhythmia. Implanting permanent pacemakers, implantable cardioverter defibrillators (ICDs) and Cardiac Resynchronisation Therapy devices (CRTs). After successfully set up the only electrophysiology lab in the country; performing electrophysiological studies and radiofrequency ablation
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...